It depends... it may be that they pulled a fast one on traders and investors to pile in so that they could cap raise at a higher $ value. Per the discussion in the prior thread, the results, at least thus far, are not better than SoC. But their claim is that their NK cells in tandem with SoC delivers superior results.
So some unwitting poor retail mugs piled in thinking they were about to make millions on the next cancer treatment, but instead CHM pulls a dirty on them today.
I'm not saying that this definitely is the way things went down, but given this possible explanation, the pause into the trading day, trading halt and announcement of findings is not odd.
CHM Price at posting:
0.8¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)